Browsing: FDA

Suzetrigine, a non-opioid pain reliever recently approved in the U.S., targets pain at the source without the risk of addiction. Can it change pain management for good?

Red No. 3 banned in the U.S. over cancer risks, but is it still lurking in your favourite snacks? What does this mean for food safety in Asia?

The Food and Drug Administration (FDA) has issued a public alert regarding a recall by CJ Foods Philippines due to the presence of an undeclared allergen – eggs – in their products.

The Food and Drug Administration (FDA) has issued a public health warning concerning purchasing and using 17 unregistered drug products.

The Food and Drug Administration (FDA) has revealed plans to establish a task force to target online sellers engaged in distributing fake products and deceptive advertising. 

This is executed in a significant move to fortify consumer protection and combat the rising tide of counterfeit goods. This initiative is particularly pertinent given the growing concerns surrounding dubious skincare and supplement products, predominantly marketed through social media platforms.

In a recent announcement, the Food and Drug Administration (FDA) has urged healthcare professionals to promptly report any adverse reactions linked to the use of anaesthesia. This directive comes in response to mounting concerns raised by healthcare practitioners regarding the efficacy of certain anaesthesia products. Particularly, those containing bupivacaine, a potent local anaesthetic, have drawn significant attention. The FDA’s stance aims to address these concerns and ensure patient safety in anaesthesia administration.

FDA’s impending proposal to ban certain carcinogenic chemicals in hair straighteners highlights a stride towards better health measures.

The US Food and Drug Administration (FDA) has greenlit new COVID-19 boosters for both Moderna and Pfizer, marking a proactive step in the fight against rapidly spreading infections in the country. Concurrently, Moderna and Pfizer have announced that their updated COVID-19 vaccines show a robust response against the BA.2.86 subvariant, a mutated version of the coronavirus.